Reata Pharma (RETA)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | RETA | CGON | BLTE | ||
| Company | Reata Pharma | Cg Oncology Inc | Belite Bio Inc ADR | ||
| Price Information | |||||
| Exchange | NASDAQ | NASDAQ | NASDAQ | ||
| Open | 172.34 | 74.97 | 161.67 | ||
| High | 172.46 | 76.20 | 164.30 | ||
| Low | 172.32 | 73.51 | 161.67 | ||
| Last | 172.36 | 75.10 | 163.05 | ||
| Change | +0.04 | +0.25 | +2.38 | ||
| Percent Change | +0.02% | +0.33% | +1.48% | ||
| Volume | 1,988,500 | 611,500 | 126,400 | ||
| 20-Day Average Volume | 810,510 | 904,380 | 158,135 | ||
| Previous | 172.32 | 74.85 | 160.67 | ||
| Industry | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | ||
| Has Options | No | Yes | No | ||
| Technicals | |||||
| 20-Day Moving Average | 170.84 | 71.63 | 155.21 | ||
| 20-Day Raw Stochastic | 97.36% | 85.07% | 93.82% | ||
| 20-Day Relative Strength | 81.56 | 57.26 | 57.50 | ||
| Weighted Alpha | +177.60 | +146.44 | +105.24 | ||
| Today's Opinion | 100% Buy | 88% Buy | 56% Buy | ||
| Yesterday's Opinion | 100% Buy | 88% Buy | 56% Buy | ||
| Last Month's Opinion | 100% Buy | 100% Buy | 8% Buy | ||
| Performance | |||||
| 5-Days | |||||
| %Chg | +0.18% since 09/18/23 | +5.49% since 07/31/26 | +2.80% since 07/31/26 | ||
| Low | 171.96 on 09/19/23 | 68.08 on 08/03/26 | 152.88 on 08/03/26 | ||
| High | 172.46 on 09/25/23 | 76.50 on 08/06/26 | 164.30 on 08/07/26 | ||
| 1-Month | |||||
| %Chg | +1.99% since 08/25/23 | +8.53% since 07/07/26 | +3.40% since 07/07/26 | ||
| Low | 168.67 on 09/05/23 | 67.12 on 07/30/26 | 144.06 on 07/14/26 | ||
| High | 172.46 on 09/25/23 | 76.50 on 08/06/26 | 164.30 on 08/07/26 | ||
| 3-Month | |||||
| %Chg | +83.77% since 06/23/23 | +8.56% since 05/07/26 | +4.52% since 05/07/26 | ||
| Low | 88.80 on 06/27/23 | 53.21 on 06/08/26 | 130.00 on 06/02/26 | ||
| High | 172.46 on 09/25/23 | 77.00 on 06/30/26 | 164.30 on 08/07/26 | ||
| 6-Month | |||||
| %Chg | +101.14% since 03/24/23 | +49.13% since 02/06/26 | -13.21% since 02/06/26 | ||
| Low | 76.54 on 05/10/23 | 49.25 on 02/09/26 | 130.00 on 06/02/26 | ||
| High | 172.46 on 09/25/23 | 77.00 on 06/30/26 | 192.28 on 02/27/26 | ||
| Key Statistics | |||||
| Market Capitalization, $K | 6,575,535 | 6,623,971 | 6,535,858 | ||
| Shares Outstanding, K | 38,150 | 88,202 | 40,085 | ||
| Annual Sales, $M | 2,220,000 | 4,040,000 | 0 | ||
| Annual Net Income, $M | -311,900,000 | -161,000,000 | -77,610,000 | ||
| Last Qtr Sales, $M | 22,750,000 | 1,080,000 | 0 | ||
| Last Qtr Income, $M | 193,000,000 | -60,200,000 | -26,940,000 | ||
| 60-Month Beta | 1.42 | 0.23 | -1.22 | ||
| Per-Share Information | |||||
| Most Recent Earnings | -2.32 on 08/08/23 | -0.71 on 05/08/26 | -0.34 on 05/20/26 | ||
| Latest Earnings Date | 11/14/23 | 11/13/26 | 08/13/26 | ||
| Most Recent Dividend | N/A | N/A | N/A | ||
| Next Ex-Dividend Date | N/A | N/A | N/A | ||
| Ratios | |||||
| Price/Earnings ttm | 0.00 | 0.00 | 0.00 | ||